Short Decsription
Creative Biolabs offers CHO-K1-Tg(Human Gα16//Human Gαqi5//Human GPR151 Receptor) Division-Arrested Cell which GPR151 receptor stably expressed in CHO-K1 cells which overexpress Gα16 and Gαqi5.
Description
CHO-K1-Tg(Human Gα16//Human Gαqi5//Human GPR151 Receptor) Division-Arrested Cell was engineered to express the receptor human GPR151 (NM_194251), Gα16 and Gαqi5 gene. This cell line can be used to study GPR151 receptor function, signaling pathways, and potential therapeutic interventions. Dividing-arrest cells are cells that are normally kept under specific culture conditions or treated with agents that prevent cell division from being held in a non-dividing state. This can be achieved through methods such as serum starvation, chemical inhibitors of cell cycle progression, or genetic modification.
Features
Well-characterized stable cell lines;
for cell-based high-throughput screening;
Low-cost evaluation of stable cell lines or limited quantities of compounds.
Applications
GPR151 receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
GPR151
Receptor Family
Orphan
Species
Human
Parental Cell Line
CHO-K1 Gα16 Gαqi5
Transfection
Full-length Human GPR151 (GenBank Accession Number NM_194251) with FLAG-tag sequence at the N-terminus
Gene
NM_194251
Background
The diverse physiological effects of Galanin, a biologically active neuropeptide, are mediated through cell surface G protein-coupled receptors. There are three galanin receptor subtypes, GALR1, GALR2 and GALR3 that have been widely used and Recently, a new GPCR, GalRL4 have been identified, termed as GPR151, which shows 41-43% similarity at the amino-acid level with the galanin-receptor subfamily. Galanin, widely distributed in the central and peripheral nervous systems and the endocrine systems, binds to galanin receptors to induce several regulatory functions in neuronal cells, including neuroregeneration, control of endocrine and exocrine secretions, and modulation of sensory and behavioral functions. Galanin agonists have been shown to have therapeutic application in treatment of chronic pain; galanin antagonists have therapeutic potential in treatment of Alzheimer's disease, depression, and feeding disorders.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.